These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27470401)

  • 1. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
    Guo Q; Qian Z; Yan D; Li L; Huang L
    Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
    Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
    Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism study of miR-125b in occurrence and progression of multiple myeloma.
    Gao D; Xiao Z; Li HP; Han DH; Zhang YP
    Cancer Med; 2018 Jan; 7(1):134-145. PubMed ID: 29214735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
    Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
    Xu J; Xu W; Yang X; Liu Z; Sun Q
    Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.
    Cai P; Li G; Wu M; Zhang B; Bai H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
    Chen J; Peng X; Dai Y
    Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
    Qiao Q; Li H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):507-12. PubMed ID: 27381864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
    Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
    Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.
    Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X
    BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway.
    Chen L; Wang J; Li JW; Zhao XW; Tian LF
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):581-590. PubMed ID: 32016959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.
    Yao J; Zheng K; Li C; Liu H; Shan X
    Med Oncol; 2015 Jun; 32(6):610. PubMed ID: 25920606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
    Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
    Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.